COVID-19 pneumonia: Procalcitonin for risk assessment

The biomarker Procalcitonin (PCT) is widely used to assess the risk of bacterial infection and progression to severe sepsis and…

Controlling hypertension during the COVID-19 pandemic

How should clinicians navigate clinical uncertainty for patients who are taking angiotensinconverting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs)?

Discovery: Important additional function of protective eye protein

The lens of the human eye comprises a highly concentrated protein solution, which lends the lens its great refractive power.

Probiotic reduces crying in colicky infants

Evidence is mounting that probiotics can give babies relief from colic, a functional gastrointestinal disorder believed to be tied to…

Medical Chronicle May 2020 CPDs

These are the two diabetes CPDs produced for the May 2020 issue of Medical Chronicle, together accredited for 3 general…

Read More
CPD POINTS: 3

Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30

Approximately 1.6 billion people worldwide are Muslims. Ramadan is the ninth month of the Islamic calendar, and fasting (total abstinence…

Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes

Premix insulin analogues are a well-established treatment for type 2 diabetes (T2D). However, there is a lack of simple, clear…

First-trimester preeclampsia screening with biomarkers

Preeclampsia is a grave threat to maternal and infant health, with a growing prevalence in the developing world. But are…

Read More
CPD POINTS: 1

Mental health in the time of Covid-19

In a new paper published in The Lancet Psychiatry (April 2020), researchers warn that coronavirus disease 2019 (Covid-19) has had…

Caring for the carers

The World Federation of Mental Health (WFMH) describes caregiver burden as a ‘global problem’ that negatively impacts the quality of…

Specialist Forum May 2020 CPDs

These are the CPDs produced for the May 2020 issue of Specialist Forum, together accredited for 3 general points.

Read More
CPD POINTS: 3

Improving melanoma patients’ survival odds

Melanoma accounts for between 1% and 4% of skin cancers and occurs when the pigment-producing cells that give colour to the…

From pot to pill

In last month’s issue, we looked at the effects of cannabidiol (CBD), a cannabis‐derived medicinal product, on the body’s natural…

How can health workers manage their mental health during COVID-19?

The South African Depression and Anxiety Group (SADAG) has been receiving more calls since the start of lockdown from people…

Read More
CPD POINTS: 1

Alternatives to hazardous chemicals in medical devices

Medical devices play a critical role in healthcare but may contain hazardous substances in their composition that can leach into…

Medical cannabis – what’s the evidence?

Clinical evidence of the indications for the use of medical cannabis is currently supported by a limited evidence base, but…

Talking to patients about codeine

Because codeine can also cause euphoriant effects, which reinforce continued use, it poses a risk of developing tolerance and eventually…

Etifoxine – a unique anxiolytic

Prescribing drugs for anxiety disorders is one of a psychiatrist’s most common tasks. Etifoxine has clear advantages over other commonly…

Read More
CPD POINTS: 1

New concepts in an old disease

Gout is characterised by recurrent acute joint inflammation (gouty arthritis) in the extremities, caused by crystals that are deposited in…

Medical cannabis – what’s the evidence?

Clinical evidence of the indications for the use of medical cannabis is currently supported by a limited evidence base, but…

« » page 1 / 29